Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Adenoma Sebaceum

3,4-dihydroxyphenylglycol has been researched along with Adenoma Sebaceum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbiser, JL; Bhattacharya, A; Chévere-Torres, I; Gambello, MJ; Kang, A; Kaphzan, H; Klann, E; Maki, JM; Santini, E1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylglycol and Adenoma Sebaceum

ArticleYear
Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.
    Neurobiology of disease, 2012, Volume: 45, Issue:3

    Topics: Analysis of Variance; Animals; Animals, Newborn; Biophysics; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agents; GTPase-Activating Proteins; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Patch-Clamp Techniques; Receptors, Metabotropic Glutamate; Ribosomal Protein S6 Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2012